Compare TY & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TY | PRGO |
|---|---|---|
| Founded | 1929 | 1887 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.5B |
| IPO Year | N/A | 2013 |
| Metric | TY | PRGO |
|---|---|---|
| Price | $34.51 | $11.17 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $19.33 |
| AVG Volume (30 Days) | 27.4K | ★ 2.2M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | 3.36% | ★ 10.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 4.78 | N/A |
| Revenue | N/A | ★ $800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.02 |
| P/E Ratio | $7.19 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $30.53 | $9.23 |
| 52 Week High | $35.05 | $28.44 |
| Indicator | TY | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 62.65 | 49.34 |
| Support Level | $33.25 | $10.40 |
| Resistance Level | $34.76 | $12.36 |
| Average True Range (ATR) | 0.36 | 0.48 |
| MACD | -0.06 | -0.10 |
| Stochastic Oscillator | 60.68 | 31.31 |
Tri-Continental Corp is a closed-end management investment company. It invests to produce future growth of both capital and income while providing reasonable current income. The fund is divided into two equal segments namely, the equity segment uses quantitative models to select individual stocks whereas the Flexible capital income segment invests across a company's investable capital structure, including stocks, bonds, and convertible securities. The Fund invests in a range of sectors, which include consumer discretionary, consumer staples, energy, financials, healthcare, industrials, information technology, industrials, materials, real estate, telecommunication services, utilities, aerospace and defense, banking, chemicals, and others.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.